NCT05202379View on ClinicalTrials.gov

CC-42344 Safety Study in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

March 29, 2023

Study Completion Date

March 29, 2023

Conditions
Influenza A
Interventions
DRUG

CC-42344

CC-42344 capsules

DRUG

Placebo

Placebo capsules

Trial Locations (1)

6009

Linear Clinical Research, Nedlands

Sponsors

Collaborators (1)

Linear Clinical Research
All Listed Sponsors
collaborator

Cocrystal Pharma Australia Pty Ltd.

UNKNOWN

collaborator

Linear Clinical Research

INDUSTRY

lead

Cocrystal Pharma, Inc.

INDUSTRY